TY - CHAP
T1 - Isolation of extracellular vesicles using titanium dioxide microspheres
AU - Santiago, Veronica Feijoli
AU - Rosa-Fernandes, Livia
AU - Macedo-da-Silva, Janaina
AU - Angeli, Claudia B.
AU - Mule, Simon Ngao
AU - Marinho, Claudio R. F.
AU - Torrecilhas, Ana Claudia
AU - Marie, Suely N. K.
AU - Palmisano, Giuseppe
PY - 2024
Y1 - 2024
N2 - Extracellular vesicles (EVs) are bilayer membrane particles released from several cell types to the extracellular environment. EVs have a crucial role in cell-cell communication, involving different biological processes in health and diseases. Due to the potential of biomarkers for several diseases as diagnostic and therapeutic tools, it is relevant to understand the biology of the EVs and their content. One of the current challenges involving EVs is regarding the purification method, which is a critical step for EV’s functional and characterization studies. Ultracentrifugation is the most used method for EV isolation, where the nanoparticles are separated in sequential centrifugation to isolate the EVs based on their size. However, for viscous biofluids such as plasma, there is a co-isolation of the most abundant proteins, which can impair the EV’s protein identification due to the low abundance of these proteins and signal suppression by the most abundant plasma proteins. Emerging techniques have gained attention in recent years. Titanium dioxide (TiO2) is one of the most promising techniques due to its property for selective isolation based on the interaction with phospholipids in the EV membrane. Using a small amount of TiO2 beads and a low volume of plasma, it is possible to isolate EVs with reduced plasma protein co-isolation. This study describes a comprehensive workflow for the isolation and characterization of plasma extracellular vesicles (EVs) using mass spectrometry-based proteomics techniques. The aim of this chapter is describe the EV isolation using TiO2 beads enrichment and high-throughput mass spectrometry techniques to efficiently identify the protein composition of EVs in a fast and straightforward manner.
AB - Extracellular vesicles (EVs) are bilayer membrane particles released from several cell types to the extracellular environment. EVs have a crucial role in cell-cell communication, involving different biological processes in health and diseases. Due to the potential of biomarkers for several diseases as diagnostic and therapeutic tools, it is relevant to understand the biology of the EVs and their content. One of the current challenges involving EVs is regarding the purification method, which is a critical step for EV’s functional and characterization studies. Ultracentrifugation is the most used method for EV isolation, where the nanoparticles are separated in sequential centrifugation to isolate the EVs based on their size. However, for viscous biofluids such as plasma, there is a co-isolation of the most abundant proteins, which can impair the EV’s protein identification due to the low abundance of these proteins and signal suppression by the most abundant plasma proteins. Emerging techniques have gained attention in recent years. Titanium dioxide (TiO2) is one of the most promising techniques due to its property for selective isolation based on the interaction with phospholipids in the EV membrane. Using a small amount of TiO2 beads and a low volume of plasma, it is possible to isolate EVs with reduced plasma protein co-isolation. This study describes a comprehensive workflow for the isolation and characterization of plasma extracellular vesicles (EVs) using mass spectrometry-based proteomics techniques. The aim of this chapter is describe the EV isolation using TiO2 beads enrichment and high-throughput mass spectrometry techniques to efficiently identify the protein composition of EVs in a fast and straightforward manner.
KW - Extracellular vesicles
KW - MALDI-TOF MS
KW - Mass spectrometry
KW - Proteomics
KW - Titanium dioxide beads
UR - https://www.scopus.com/pages/publications/85186749563
U2 - 10.1007/978-3-031-50624-6_1
DO - 10.1007/978-3-031-50624-6_1
M3 - Chapter
C2 - 38409413
AN - SCOPUS:85186749563
SN - 9783031506239
T3 - Advances in Experimental Medicine and Biology
SP - 1
EP - 22
BT - Mass spectrometry-based approaches for treating human diseases and diagnostics
A2 - Verano-Braga, Thiago
PB - Springer
CY - Switzerland
ER -